(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-(4-hydroxyMethyl-piperidin-1-yl)-Methanone

$400 - $469
Product name: (2,3-Dihydro-benzo[1,4]dioxin-2-yl)-(4-hydroxyMethyl-piperidin-1-yl)-Methanone
CAS: 1178713-03-5
MF: C15H19NO4
MW: 277.32
EINECS:
MDL Number:
Synonyms:(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-(4-hydroxyMethyl-piperidin-1-yl)-Methanone;(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxyMethyl)piperidin-1-yl)Methanone;Methanone, (2,3-dihydro-1,4-benzodioxin-2-yl)[4-(hydroxymethyl)-1-piperidinyl]-

Price3 Properties Safety Information Description

3 prices

Selected condition：

Brand

Package

ManufacturerAlichem
Product number1178713035
Product description(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone
Packaging1g
Price$400
Updated2021-12-16
Buy

ManufacturerChemenu
Product numberCM159589
Product description(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95%
Packaging1g
Price$439
Updated2021-12-16
Buy

ManufacturerCrysdot
Product numberCD11340131
Product description(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95+%
Packaging1g
Price$469
Updated2021-12-16
Buy

Manufacturer	Product number	Product description	Packaging	Price	Updated	Buy
Alichem	1178713035	(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone	1g	$400	2021-12-16	Buy
Chemenu	CM159589	(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95%	1g	$439	2021-12-16	Buy
Crysdot	CD11340131	(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(4-(hydroxymethyl)piperidin-1-yl)methanone 95+%	1g	$469	2021-12-16	Buy

Properties

Boiling point :475.7±45.0 °C(Predicted)
Density :1.250±0.06 g/cm3(Predicted)
pka :14.94±0.10(Predicted)

Symbol(GHS):

Signal word:

Hazard statements:

Code	Hazard statements	Hazard class	Category	Signal word	Pictogram	P-Codes

Precautionary statements:

Amadis Chemical Company Limited Meryer (Shanghai) Chemical Technology Co., Ltd. Amber MolTech LLC BePharm Ltd Shanghai Sunway Pharmaceutical Technology Co.,Ltd. Bide Pharmatech Ltd.